RANIERI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 7.970
EU - Europa 7.283
AS - Asia 4.775
SA - Sud America 613
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 6
Totale 20.727
Nazione #
US - Stati Uniti d'America 7.863
CN - Cina 1.816
IE - Irlanda 1.649
SG - Singapore 1.573
UA - Ucraina 1.099
RU - Federazione Russa 913
IT - Italia 911
SE - Svezia 857
DE - Germania 611
BR - Brasile 504
FR - Francia 472
HK - Hong Kong 405
FI - Finlandia 375
IN - India 295
TR - Turchia 251
VN - Vietnam 207
GB - Regno Unito 149
CZ - Repubblica Ceca 60
CA - Canada 55
NL - Olanda 47
AR - Argentina 34
MX - Messico 33
BD - Bangladesh 32
BE - Belgio 31
JP - Giappone 30
AT - Austria 28
IQ - Iraq 26
ES - Italia 25
PL - Polonia 24
ZA - Sudafrica 22
PK - Pakistan 19
EC - Ecuador 18
CL - Cile 14
PH - Filippine 13
VE - Venezuela 13
PY - Paraguay 12
AZ - Azerbaigian 11
ID - Indonesia 11
JO - Giordania 11
LT - Lituania 11
MA - Marocco 11
UZ - Uzbekistan 11
SA - Arabia Saudita 10
EU - Europa 9
KE - Kenya 8
MY - Malesia 8
CO - Colombia 7
AE - Emirati Arabi Uniti 6
IR - Iran 6
ET - Etiopia 5
IL - Israele 5
RO - Romania 5
UY - Uruguay 5
EG - Egitto 4
HN - Honduras 4
LB - Libano 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
JM - Giamaica 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
PE - Perù 3
TN - Tunisia 3
AL - Albania 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CM - Camerun 2
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
KW - Kuwait 2
NG - Nigeria 2
PT - Portogallo 2
QA - Qatar 2
SR - Suriname 2
SY - Repubblica araba siriana 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
DM - Dominica 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
MW - Malawi 1
Totale 20.718
Città #
Dublin 1.649
San Jose 1.046
Chandler 999
Singapore 787
Jacksonville 772
Ashburn 561
Nyköping 548
Dearborn 541
Munich 412
Hong Kong 400
Nanjing 380
Beijing 326
Dallas 244
Wilmington 239
New York 237
Santa Clara 219
Helsinki 206
Princeton 179
Lauterbourg 169
San Mateo 157
Nanchang 145
Ann Arbor 122
Boardman 119
Moscow 117
Foggia 98
Shenyang 85
Woodbridge 83
The Dalles 80
Bari 79
Los Angeles 75
Des Moines 73
Ho Chi Minh City 72
Tianjin 69
Hebei 68
Milan 60
Rome 54
Brno 53
Seattle 53
Kunming 51
Hanoi 47
Jiaxing 45
Changsha 43
São Paulo 38
Pune 37
Hangzhou 34
Jinan 30
Brussels 29
Falls Church 29
Shanghai 29
Guangzhou 28
Tokyo 27
Toronto 26
Brooklyn 25
Hilden 25
Zhengzhou 25
Ningbo 23
San Francisco 22
Augusta 20
Frankfurt am Main 20
Warsaw 20
London 19
Rio de Janeiro 19
Naples 17
Noci 17
Norwalk 17
Taizhou 17
Changchun 16
Houston 16
Lanzhou 16
Fuzhou 15
Stevenage 15
Belo Horizonte 14
Chicago 14
Orem 14
Auburn Hills 13
Atlanta 12
Hillsboro 12
Manchester 12
Nuremberg 12
Chennai 11
Florence 11
Paris 11
Turku 11
Vienna 11
Catania 10
Manfredonia 10
Phoenix 10
Saint Petersburg 10
Stockholm 10
Amman 9
Baghdad 9
Baku 9
Boston 9
Falkenstein 9
Haiphong 9
Johannesburg 9
Jyväskylä 9
Leawood 9
Mexico City 9
Orange 9
Totale 12.740
Nome #
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 465
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 280
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 270
CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression 251
Metodo per il dosaggio del fattore di crescita epidermico (EGF) e del peptide-1 chemiotattico dei monociti umani (MCP-1) in un campione biologico e relativo kit diagnostico 245
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 181
Biosynthesis of C3 by human mesangial cells. Modulation by proinflammatory cytokines. 172
Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells 165
Tumori del rene e della via urinaria: cosa deve sapere il nefrologo 163
The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. 161
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità. 160
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 159
GLI INIBITORI DELLA TRASCRITTASI INVERSA (RT) DOWN-REGOLANO LA PROLIFERAZIONE CELLULARE E INDUCONO IL DIFFERENZIAMENTO NEL CARCINOMA RENALE A CELLULE CHIARE. 158
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation 158
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 155
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. 154
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 154
cell carcinoma cell line and use thereof. 152
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. 150
Trapidil inhibits human mesangial cells proliferation: effect on PDGF-β receptor binding and expression 149
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 147
CD2AP mutations are associated with sporadic nephrotic sindrome and focal segmental glomerulosclerosis (FSGS). 144
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 143
WAIT AND SEE: IS IT A POSSIBLE OPTION IN ASYMPTOMATIC PATIENTS WITH MESH EXPOSURE? 143
Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes 141
Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells. 138
Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 138
Jak3 mutations predict poor survival in patients with clear cell renal carcinoma 136
Renal cortical complement C3 gene expression in IgA nephropathy 135
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): PKD1 AND PKD2 MUTATIONAL SCREENING IN 100 ITALIAN PATIENTS 135
Atti 52° Congresso Nazionale della Società Italiana di Nefrologia. Genova, 21-24 Settembre, 2011 135
IgA nephropathy: pros and cons for a familial disease. 134
“Concentrazioni urinarie di EGF (epidermal growth factor) urinario in bambini affetti da grave uropatia ostruttiva e da reflusso”. 133
BEAT: Bioinformatics Exon Array Tool to store, analyze and visualize Affymetrix GeneChip Human Exon Array data from disease experiments. 132
“Urinary excretion and renal expression of monocyte chemotactive peptide-1 (MCP-1) and epidermal growth factor expression (EGF) in children with reflux and obstructive nephropathies 131
REVERSE TRANSCRIPTASE (RT) INHIBITORS INDUCE DIFFERENTIATION AND UPREGULATE MHC CLASS I IN HUMAN RENAL CLEAR CELL CARCINOMA. 131
Renal and upper urinary tract tumors: what the nephrologist should know 129
Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy. 129
CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn. 129
[Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?] 129
ESCREZIONE URINARIA DI MONOCYTE CHEMOTACTIC PEPTIDE-1 ED EPIDERMAL GROWTH FACTOR NELL’UROPATIA OSTRUTTIVA IN ETÀ PEDIATRICA 128
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells. 127
Renal Carcinoma Cell Line and Use Thereof 127
Espressione renale di epidermal growth factor (EGF) e monocyte chemotactic peptide-1 (MCP-1) in bambini affetti da stenosi del giunto pielo-ureterale. 127
Linea cellulare di carcinoma renale e suo uso 127
IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro. 125
Renal expression and urinary concentration of EGF and IL-6 in acutely dysfunctioning kidney transplanted patients 125
Proteomic profile of CD24+ CD133+ renal multipotent progenitors (RMP) 124
Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. 123
Biosimilar: can we manage biopharmaceutical heterogeneity? 122
Altered phosphorylation of cytoskeleton proteins in peripheral blood mononuclear cells characterizes chronic antibody-mediated rejection in kidney transplantation 122
JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8+ T cells in renal cell carcinoma patients 121
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma. 120
Urine profiling by SELDI-TOF/MS: Monitoring of the critical steps in sample collection, handling and analysis 120
Reclassification of glomerulopathies: which role for the podocyte? 118
Beyond pre-analytical and analytical concerns in the study of synovial fluid proteome: Description of an optimized gel-based protocol 118
Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis 117
Urine protein profile of IgA nephropathy may predict the response to ACE-inhibitor therapy 117
POTENTIAL SALIVARY PROTEOMIC MARKERS OF ORAL SQUAMOUS CELL CARCINOMA 117
Salivary proteomic signatures of oral squamous cell carcinoma. 117
Diagnostic and prognostic markers of renal cell carcinoma 117
CD40 cross-linking induces migration of renal tumor cell through nuclear factor of activated T cells (NFAT) activation 117
Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. 117
Altered expression of the clock gene machinery in kidney cancer patients 116
Espressione renale di PAI-1 (Plasminogen activator inhibitor-1) ed angiotensinogeno (AGT) in bambini con nefropatia ostruttiva (NO). 115
Urinary epidermal growth factor concentration in patients affected by ADPKD. 115
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activators inhibitors 115
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. 115
PROTEOMICA E RENE UN APPROCCIO INNOVATIVO ALLO STUDIO DELLE MALATTIE RENALI 114
Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunihistochemistry and in situ study. 114
Is Berger's disease a hereditary nephritis? 114
Growth factors and their receptors in the progression of renal damage. 114
Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection 114
Immunologic Response to RCC. 113
Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma. 113
Chronic rhinosinusitis with nasal polyposis (CRSwNP): the correlation between expression of Galectin-10 and Clinical-Cytological Grading (CCG) 112
Disease-associated bias in T helper type 1(Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. 111
In vitro immunogobulin production in relatives of patients with IgA Nephropathy. 110
Monitoring biological action of rapamycin in renal transplantation. 110
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy 110
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 110
Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer. 109
TLR7 and TLR8 as targets for tumor immunotherapy 108
Exposure to low- vs. iso-osmolar contrast agents induces NADPH-dependent Reactive Oxygen Species (ROS) genereration in a cellular model of renal injur 107
Ischemia-reperfusion injury-induces abnormal dendritic cell traffic in the transplanted kidney with delayed graft function 106
Platelet-derived growth factor and proliferative glomerulonephritis. 105
Expression of platelet derived growth factor receptors in normal and diseased human kidney: an immunohistochemistry and in situ study. 105
The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review 105
Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. 103
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy 103
Profiles of immunoregolatory cytokine production in vitro in patients with IgA nephropathy and their kindred 103
Ischemia-reperfusion induces glomerular and tubular activation of pro-inflammatory and anti-apoptotic pathways: differential modulation by rapamycin. 103
VHL gene alterations in Italian patients with isolated renal cell carcinomas. 103
Saliva analysis by Surface Enhanced laser Desorption/Ionization Time of Flight Mass Spectrometry (SELDI-TOF/MS): from sample collection to data analysis 102
Diabetes Mellitus (DM) reduces survival in patients with renal cell carcinoma (RCC) : role of OGG1 and tuberine 102
LPS removal reduces CD80-mediated albuminuria in critically ill patients with Gram-negative sepsis 102
Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA) 102
REVERSE TRANSCRIPTASE INHIBITORS INDUCE CELL DIFFERENTIATION AND ENHANCE THE IMMUNOGENIC PHENOTYPE IN HUMAN RENAL CELL CARCINOMA 101
Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy 101
Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. 101
Totale 13.413
Categoria #
all - tutte 106.796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.796


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021284 0 0 0 0 0 0 0 0 0 263 17 4
2021/20221.139 157 14 16 33 119 46 41 79 187 139 39 269
2022/20234.250 372 177 237 274 257 365 42 312 1.957 54 88 115
2023/20241.056 120 34 49 23 73 387 58 87 17 14 14 180
2024/20253.410 196 47 113 103 125 454 481 268 815 175 334 299
2025/20265.159 322 509 556 690 277 214 1.317 590 432 252 0 0
Totale 21.251